DEVELOPMENT AND SUPPLY AGREEMENT Between QORVO BIOTECHNOLOGIES, LLC and ZOMEDICA PHARMACEUTICALS CORP. dated NOVEMBER 26, 2018Development and Supply Agreement • February 26th, 2019 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Development and Supply Agreement (this “Agreement”), effective as of November 26, 2018 (the “Effective Date”) is entered into by and between Qorvo Biotechnologies, LLC having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447, USA (“Qorvo”), and Zomedica Pharmaceuticals Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”). Each of Qorvo and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
AMENDMENT NO. 2 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 26th, 2019 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations
ZOMEDICA PHARMACEUTICALS CORP., a body corporate duly incorporated pursuant to the laws of the Province of Alberta and having its registered office in the City of Calgary, in the Province of Alberta (hereinafter referred to as the "Corporation")
